Kairos Pharma, LTD. — All Filings
106 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
8-A12B
8-K
CERT
CORRESP
D
DEF 14A
DEF 14C
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
PRE 14C
PRER14A
S-1
S-1/A
S-3
S-8
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-008435 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001493152-26-008116 | Feb 26, 2026 | — |
| EFFECT | — | 9999999995-26-000284 | Jan 23, 2026 | — |
| CORRESP | — | 0001493152-26-002996 | Jan 21, 2026 | — |
| UPLOAD | — | 0000000000-26-000555 | Jan 15, 2026 | — |
| S-3 | S-3 | 0001493152-26-001909 | Jan 13, 2026 | — |
| 4 | 4 | 0001493152-25-029601 | Dec 30, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001493152-25-028895 | Dec 23, 2025 | Sep 16, 2025 |
| 4 | 4 | 0001493152-25-025224 | Nov 26, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001493152-25-025197 | Nov 26, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001493152-25-025198 | Nov 26, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001493152-25-025203 | Nov 26, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001493152-25-025205 | Nov 26, 2025 | Sep 16, 2025 |
| 10-Q | 10-Q | 0001493152-25-023276 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-018145 | Oct 15, 2025 | Oct 8, 2025 |
| 8-K | 8-K | 0001493152-25-017208 | Oct 7, 2025 | Oct 1, 2025 |
| 8-K | 8-K | 0001493152-25-013975 | Sep 18, 2025 | — |
| 8-K | 8-K | 0001493152-25-013040 | Sep 11, 2025 | — |
| 8-K | 8-K | 0001641172-25-026316 | Sep 3, 2025 | — |
| 424B3 | 424B3 | 0001641172-25-024858 | Aug 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003587 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-023167 | Aug 12, 2025 | Jun 30, 2025 |
| 10-K/A | 10-K/A | 0001641172-25-021134 | Jul 28, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001641172-25-019645 | Jul 15, 2025 | — |
| 8-K | 8-K | 0001641172-25-014905 | Jun 12, 2025 | Jun 10, 2025 |
| 8-K | 8-K | 0001641172-25-013368 | Jun 3, 2025 | — |
| DEFR14A | DEFR14A | 0001641172-25-011229 | May 16, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-002232 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010089 | May 14, 2025 | Mar 31, 2025 |
| PRER14A | PRER14A | 0001641172-25-008787 | May 6, 2025 | — |
| DEF 14A | DEF 14A | 0001641172-25-007922 | May 1, 2025 | Apr 30, 2025 |
| 3 | — | 0001641172-25-007758 | Apr 30, 2025 | Dec 10, 2024 |
| 10-K/A | AMENDMENT TO THE FORM 10-K | 0001641172-25-006509 | Apr 29, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001641172-25-006504 | Apr 28, 2025 | Apr 23, 2025 |
| 424B3 | — | 0001641172-25-006278 | Apr 25, 2025 | — |
| 8-K | — | 0001641172-25-005946 | Apr 24, 2025 | — |
| EFFECT | — | 9999999995-25-001242 | Apr 24, 2025 | — |
| CORRESP | — | 0001641172-25-005650 | Apr 22, 2025 | — |
| S-1 | — | 0001641172-25-005602 | Apr 22, 2025 | — |
| 10-K | — | 0001641172-25-004920 | Apr 15, 2025 | Dec 31, 2024 |
| 4 | — | 0001641172-25-002927 | Apr 7, 2025 | Jan 1, 2025 |
| NT 10-K | — | 0001641172-25-001186 | Mar 28, 2025 | Dec 31, 2024 |
| 8-K | — | 0001493152-25-010977 | Mar 20, 2025 | — |
| 8-K | — | 0001493152-25-008268 | Feb 26, 2025 | — |
| 4 | — | 0001493152-25-008105 | Feb 24, 2025 | Jan 1, 2025 |
| 4 | — | 0001493152-25-008106 | Feb 24, 2025 | Jan 1, 2025 |
| DEF 14C | — | 0001493152-25-005657 | Feb 10, 2025 | — |
| 8-K | — | 0001493152-25-005100 | Feb 6, 2025 | — |
| 424B3 | — | 0001493152-25-004882 | Feb 5, 2025 | — |
| EFFECT | — | 9999999995-25-000308 | Feb 4, 2025 | — |